Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Dermatol Pract Concept ; 14(1)2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38364385

RESUMEN

INTRODUCTION: Xeroderma pigmentosum (XP), a rare inherited condition, hallmarked by extreme sensitivity to sun exposure resulting in multiple skin cancers and non-malignant skin alterations is attributed to homozygous inactivating pathogenic variants (PVs) in DNA repair genes, predominantly the XPC gene. OBJECTIVES: Report a unique phenotypic expression of mutant XPC allele that may be compatible with a putative modifier role for MC1R polymorphism. METHODS: A family of 13 siblings, seven of whom were diagnosed with at least one cutaneous melanoma (N = 53) and non-melanoma skin cancers (N = 9) was studied. Of seven melanoma-affected cases, five consented for genetic analysis. CDKN2A revealed no PV in any case and subsequent whole-exome sequencing (WES) identified a rare homozygous missense PV (c.919C>T; p.Arg307Trp) in exon 8 of the XPC gene in all affected individuals. Notably, XPC PV carriers who co-harbored the p.I155T MC1R variant (N = 3) exhibited larger number of tumors, deeper Breslow indexes, higher rates of invasive melanomas and earlier age at diagnosis compared with non MC1R variant carriers (N = 2). CONCLUSIONS: Familial malignant melanoma phenotype may, in fact, be an unusual clinical presentation of XPC, and MC1R may be a genetic modifier of penetrance and phenotype of mutant XPC alleles.

2.
Artículo en Inglés | MEDLINE | ID: mdl-29472118

RESUMEN

OBJECTIVES: The odontogenic keratocyst (OKC) is an aggressive odontogenic cyst that has a high recurrence rate. Apart from PTCH1 mutations, few molecular alterations are described in OKCs. Low expression of microRNAs (miRNAs) miR-15a and/or miR-16-1 in association with increased expression of their target, Bcl-2, have been previously found in OKC. In humans, MIR15A and MIR16-1 are clustered at chromosome position 13 q14, and loss of heterozygosity (LOH) at this locus occurs in different tumors. We aimed to determine whether deletion at 13 q14 is a potential mechanism leading to miR-15a/16-1 aberrant expression in OKC. METHODS: Genomic DNA was extracted from 15 formalin-fixed, paraffin-embedded microdissected OKC cases. The polymorphic DNA markers D13S272 and D13S273 on chromosome 13 q14.3, around MIR15A/MIR16-1, were amplified by polymerase chain reaction. LOH was examined by capillary electrophoresis DNA-fragment analysis. RESULTS: The D13S272 marker had no LOH in 12 informative cases, whereas 2 out of 9 informative cases (22%) had LOH at the D13S273 marker. CONCLUSIONS: An LOH event at MIR15A/MIR16-1 locus is not common in OKC. The mechanism underlying the regulation of miR-15a and miR-16-1 expression in OKC remains to be determined.


Asunto(s)
Pérdida de Heterocigocidad , MicroARNs/genética , Quistes Odontogénicos/genética , Tumores Odontogénicos/genética , Proteínas Proto-Oncogénicas c-bcl-2/genética , Adolescente , Adulto , Cromosomas Humanos Par 13 , Fragmentación del ADN , Electroforesis Capilar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Quistes Odontogénicos/patología , Tumores Odontogénicos/patología , Reacción en Cadena de la Polimerasa
3.
Head Neck Pathol ; 2(4): 324-7, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20614303

RESUMEN

Odontogenic tumors composed of two or more distinct types of lesions are unusual. In this paper, a case of an odontogenic lesion characterized by simultaneous occurrence of areas of calcifying odontogenic cyst (COC) and orthokeratinized odontogenic cyst (OOC) is described. The lesion was asymptomatic and presented at the radiographic examination as a unilocular well-delimited radiolucency extending from left incisor to right premolar area in the mandible. To date, this is the first report of COC associated with an OOC.


Asunto(s)
Neoplasias Maxilomandibulares/diagnóstico , Queratinas/metabolismo , Quiste Odontogénico Calcificado/diagnóstico , Biomarcadores de Tumor/metabolismo , Supervivencia sin Enfermedad , Femenino , Humanos , Neoplasias Maxilomandibulares/metabolismo , Neoplasias Maxilomandibulares/cirugía , Quiste Odontogénico Calcificado/metabolismo , Quiste Odontogénico Calcificado/cirugía , Resultado del Tratamiento , Adulto Joven
4.
Oral Oncol ; 43(3): 252-6, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16857408

RESUMEN

Metallothionein (MT) is a protein that has been studied in several tumors as a prognostic factor and as a potential myoepithelial cell marker in breast cancer. The aims of this study were to assess the immunohistochemical staining of MT in adenoid cystic carcinomas of the salivary glands (ACC), and to analyze possible morphological and quantitative variations among the solid, cribriform, and tubular histological subtypes. MT was investigated in 15 cases of ACC using the immunohistochemical technique. All of the cases expressed the MT antigen. This expression was noteworthy in cells depicting myoepithelial differentiation. ACC with predominant tubular pattern presented a significantly lower mean index of MT immunopositivity than did solid or cribriform subtypes, while these two latter groups did not differ in terms of MT expression. Our results suggest that MT may be an important tool for immunolocalization of myoepithelial tumor cells in salivary gland neoplasms.


Asunto(s)
Carcinoma Adenoide Quístico/química , Metalotioneína/análisis , Proteínas de Neoplasias/análisis , Neoplasias de las Glándulas Salivales/química , Adulto , Anciano , Carcinoma Adenoide Quístico/patología , Transformación Celular Neoplásica/química , Transformación Celular Neoplásica/patología , Femenino , Humanos , Inmunohistoquímica/métodos , Masculino , Persona de Mediana Edad , Neoplasias de las Glándulas Salivales/patología , Glándulas Salivales/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA